KFH - LOS ANGELES
1. Target Overview & Investment Thesis
KFH - LOS ANGELES is a 492-bed suburban community hospital in LOS ANGELES, CA with $1.30B in net patient revenue and a 13.6% operating margin. The hospital serves a payer mix of 3.2% Medicare, 9.6% Medicaid, and 87.2% commercial.
Thesis: Platform Growth. Our ML models identify $96.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.6% to 20.9% (+736bps).
| Net Revenue HCRIS | $1.30B |
| Current EBITDA COMPUTED | $176.8M |
| Operating Margin COMPUTED | 13.6% |
| Occupancy HCRIS | 68.6% |
| Revenue / Bed COMPUTED | $2.7M |
| Net-to-Gross HCRIS | 35.0% |
| Distress Probability ML | 43.9% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 13.6% places it above the state median. Among 108 size-comparable peers (246-984 beds), the median margin is -5.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (246-984), prioritizing same-state peers. 108 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| KFH - LOS ANGELES (Target) | CA | 492 | $1.30B | 13.6% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| UCSF MEDICAL CENTER | CA | 834 | $5.44B | -5.4% |
| CEDARS-SINAI MEDICAL CENTER | CA | 908 | $3.92B | -5.5% |
| UC DAVIS MEDICAL CENTER | CA | 666 | $3.28B | -11.5% |
| UCSD MEDICAL CENTER | CA | 718 | $3.06B | -7.2% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
| SANTA CLARA VALLEY MEDICAL CEN | CA | 805 | $2.55B | -29.4% |
| LUCILE PACKARD CHILDRENS HOSPI | CA | 394 | $2.39B | -0.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $96.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $27.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $26.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $25.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $15.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $835K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $176.8M |
| + RCM Uplift | +$96.0M |
| Pro Forma EBITDA | $272.9M |
| Current Margin | 13.6% |
| Pro Forma Margin | 20.9% |
| WC Released (1x) | $50.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $272.1M | $2.13B | 7.82x | 50.9% |
| Base (11x exit) | 10.0x | 11.0x | $272.1M | $2.43B | 8.92x | 54.9% |
| Bull Case | 9.0x | 11.0x | $244.9M | $2.83B | 11.57x | 63.2% |
| Bull (12x exit) | 9.0x | 12.0x | $244.9M | $3.16B | 12.92x | 66.8% |
| Bear Case | 11.0x | 10.0x | $299.3M | $1.56B | 5.21x | 39.1% |
| Bear (11x exit) | 11.0x | 11.0x | $299.3M | $1.81B | 6.05x | 43.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 108 hospitals with 246-984 beds
- Same-state prioritization (n=109)
- Comp margins: P25=-14.7% / P50=-5.4% / P75=2.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.